2023
DOI: 10.1080/13696998.2023.2226007
|View full text |Cite
|
Sign up to set email alerts
|

Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan

Hala H. Halawah,
Nimer S. Alkhatib,
Abdulaali R. Almutairi
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
references
References 20 publications
0
0
0
Order By: Relevance